These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

733 related items for PubMed ID: 24236824

  • 1. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
    Wang Y, Yang H, Xu H, Lu X, Sang X, Zhong S, Huang J, Mao Y.
    J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
    [Abstract] [Full Text] [Related]

  • 2. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY, Li N, Ding HG, Jiang FF.
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [Abstract] [Full Text] [Related]

  • 3. [Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].
    Yang Y, Xiao L, Mao R, Zhang H, Wen H, Zhao HR, He FP, Zhang YF, Bao YX.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):920-4. PubMed ID: 23522254
    [Abstract] [Full Text] [Related]

  • 4. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL, Yang HY, Xu HF, Sang XT, Lu X, Yang ZY, Zhang JC, Zhong SX, Huang JF, Zhang HB.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):948-51. PubMed ID: 18756964
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous measurements of serum AFP, GPC-3 and HCCR for diagnosing hepatocellular carcinoma.
    Qiao SS, Cui ZQ, Gong L, Han H, Chen PC, Guo LM, Yu X, Wei YH, Ha SA, Kim JW, Jin ZT, Li S, Peng JR, Leng XS.
    Hepatogastroenterology; 2011 Apr 08; 58(110-111):1718-24. PubMed ID: 21940340
    [Abstract] [Full Text] [Related]

  • 6. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J, Long F, Peng T, Hu LB, Cai H, Chen R, Chen WL.
    Eur Rev Med Pharmacol Sci; 2019 Apr 08; 23(8):3302-3310. PubMed ID: 31081083
    [Abstract] [Full Text] [Related]

  • 7. [Value of combined detection of GP73 and alpha-fetoprotein in diagonosis of hepatocellular carcinoma].
    Wu QP, Xie FY, Meng QL, Mu YY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr 08; 26(2):148-9. PubMed ID: 23002561
    [Abstract] [Full Text] [Related]

  • 8. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
    Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM.
    J Hepatol; 2005 Dec 08; 43(6):1007-12. PubMed ID: 16137783
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P.
    J Gastroenterol Hepatol; 2010 Jan 08; 25(1):129-37. PubMed ID: 19793164
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.
    Ozkan H, Erdal H, Tutkak H, Karaeren Z, Yakut M, Yüksel O, Köklü S.
    Digestion; 2011 Jan 08; 83(1-2):83-8. PubMed ID: 21042019
    [Abstract] [Full Text] [Related]

  • 11. The Value of GPC3 and GP73 in Clinical Diagnosis of Hepatocellular Carcinoma.
    Jing JS, Ye W, Jiang YK, Ma J, Zhu MQ, Ma JM, Zhou H, Yu LQ, Yang YF, Wang SC.
    Clin Lab; 2017 Nov 01; 63(11):1903-1909. PubMed ID: 29226636
    [Abstract] [Full Text] [Related]

  • 12. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
    Zhao Y, Li Y, Hu B, He X, Huang J, Zhan M, Lu L.
    Zhonghua Yi Xue Za Zhi; 2014 Feb 11; 94(5):390-2. PubMed ID: 24746091
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
    Gao G, Dong F, Xu X, Hu A, Hu Y.
    Int J Clin Exp Pathol; 2015 Feb 11; 8(9):11379-85. PubMed ID: 26617863
    [Abstract] [Full Text] [Related]

  • 14. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, Wang N, Niu Y, Wu Z, Zhou J, Qiu SJ, Shi YH, Yu B, Tang N, Chu W, Wang M, Wu J, Zhang Z, Yang S, Gu J, Wang H, Qin W.
    Lancet Oncol; 2012 Aug 11; 13(8):817-26. PubMed ID: 22738799
    [Abstract] [Full Text] [Related]

  • 15. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K, Nakagawa M, Sekiya R, Hemken PM, Sokoll LJ, Elliott D, Chan DW, Dowell BL.
    Clin Chem Lab Med; 2011 Apr 11; 49(4):711-8. PubMed ID: 21231906
    [Abstract] [Full Text] [Related]

  • 16. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
    Mao Y, Yang H, Xu H, Lu X, Sang X, Du S, Zhao H, Chen W, Xu Y, Chi T, Yang Z, Cai J, Li H, Chen J, Zhong S, Mohanti SR, Lopez-Soler R, Millis JM, Huang J, Zhang H.
    Gut; 2010 Dec 11; 59(12):1687-93. PubMed ID: 20876776
    [Abstract] [Full Text] [Related]

  • 17. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 11; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
    Xu WJ, Guo BL, Han YG, Shi L, Ma WS.
    Tumour Biol; 2014 Dec 11; 35(12):12069-74. PubMed ID: 25209179
    [Abstract] [Full Text] [Related]

  • 19. [Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma].
    Bao YX, Yang Y, Zhao HR, Mao R, Xiao L, Zhang YF, Aisiker T, Wen H.
    Zhonghua Zhong Liu Za Zhi; 2013 Jul 11; 35(7):505-8. PubMed ID: 24257301
    [Abstract] [Full Text] [Related]

  • 20. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
    Zhao Y, Wang M, Cui C, Zhang L, Liao F, Li H, Wu X.
    Cancer Biomark; 2015 Jul 11; 15(5):677-83. PubMed ID: 26406957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.